Veru Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.29

+0.00 (+0.00%)

As of Mar 25, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,536.7% upside

Low Target $21.76

Average Target $37.48

High Target $51.92

Current Price $2.29

Current
$2.29

Target
$37.48

$21.76 $37.48 avg $51.92

Scenario Analysis

Bear Case

$21.76

850.2%

Low target

Base Case

$37.48

+1,536.7%

Avg target

Bull Case

$51.92

+2,167.2%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$7.40

-69.1% from high

52-Week Low

$2.10

+9.0% from low

Target vs 52W High

$37.48

+406.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%